University of Oklahoma researcher Keenan Greyslak, Ph.D., has long been interested in how a mother’s diet during pregnancy and lactation may influence a child’s risk of developing metabolic diseases earlier and more severely as they age. With a new grant from the National Institutes of Health, he is furthering his investigations while taking another step toward a career in academic...
A University of Oklahoma researcher has received a five-year, $2 million grant from the National Cancer Institute to investigate how pancreatic cancer uses cholesterol to survive chemotherapy. By uncovering how tumors use this essential nutrient to grow and evade treatment, the research could identify new ways to treat one of the deadliest forms of cancer.
New research from the University of Oklahoma demonstrates how an aggressive form of breast cancer co-opts the body’s own immune system to attract nerves that fuel tumor growth.
Scientists have long known that many solid tumors contain networks of nerves, but they haven’t understood how those nerves get there. This study, published in Cell Death & Differentiation,...
Dr. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services, visited the OU Health Campus on Saturday, Aug. 1 to learn more about the University of Oklahoma’s flagship academic health system and its efforts to improve health outcomes across the state. Oz was joined by members of the Oklahoma Congressional Delegation, OU leadership and tribal partners.
The University of Oklahoma Division of Marketing and Communications, in partnership with the OU Health Marketing and Communications team, has been awarded a prestigious Heartland Emmy Award in the Commercial – Campaign category. The award recognizes their joint campaign “Never Done. Never Outdone.”
A University of Oklahoma researcher is part of an international team developing a new way to discover obesity drugs using human cells instead of animal models, an approach that could speed the development of more effective and affordable treatments. The effort is supported by a $12 million grant from the Novo Nordisk Foundation.
For decades, scientists believed that photoreceptors in the retina relied primarily on neighboring support cells, known as the retinal pigment epithelium (RPE), to remove waste. While the RPE is still responsible for clearing away the worn-out tips of photoreceptors each day, new findings from the University of Oklahoma reveal that photoreceptors also perform much of their own internal...
As faculty members helped first-year medical students into crisp white coats, the University of Oklahoma College of Medicine Class of 2030 crossed an important threshold. The annual White Coat Ceremony marked the beginning of their journey from aspiring doctors to future physicians, symbolizing the trust, compassion and responsibility that come with caring for patients.
The 217-member class...
University of Oklahoma College of Medicine researcher Jody Summers, Ph.D., has long hypothesized that inflammation plays a role in the development of myopia, or nearsightedness, in which close-up vision is clear but distance vision is blurry. Her laboratory experiments have been convincing, and now she has preliminary human data to support the theory.
Mulugeta Gebregziabher, Ph.D., a nationally and internationally recognized public health leader, researcher and educator, has been named a professor and the endowed chair of the Department of Biostatistics and Epidemiology at the University of Oklahoma Hudson College of Public Health.